News

Elixirr is an established, global, award-winning management consultancy, challenging the larger consultancies by delivering innovative and bespoke solutions to a repeat, globally recognised client base.

Elixirr, which was founded in 2009, accordingly considers itself “The Challenger Consultancy”, offering a wide range of expertise and capabilities, including defining strategy and driving business improvement with the aim of solving the challenges experienced by its clients. These challenges include: future-proofing against technological disruption; development and roll-out of new products, services and businesses; navigating a more complex and multinational regulatory environment; and project management and implementation of major change programmes.

Admission to Trading on AIM

On 9^th July 2020 admission and dealings commenced in the Ordinary Shares on AIM by way of a Placing of 11,520,738 Ordinary Shares of 0.005 pence each at 217 pence per share

Reasons for the admission

The Board believes that Admission will provide a platform to enhance and diversify the business through:

• the opportunity to enter the next phase of Elixirr’s growth strategy and make selective acquisitions to complement or enhance Elixirr’s capabilities, industries, or geographical coverage;
• the alignment, by way of share participation, of all employees’ goals with those of the business, aiding retention and enhancing Elixirr’s recruitment appeal; and
• improving the visibility of Elixirr generally.

The Perivan shareholder communications team were delighted to work with finnCap who were appointed Nominated Adviser, Sole Broker and Sole Bookrunner on the 149-page admission document.

Perivan specialise in the production and publication of financial documents relating to shareholder and investor communications for quoted companies, private companies and open and closed ended funds.